CCL2 and neoplasm: Similar to our finding upon depletion of macrophages, inhibition of macrophage recruitment to the biopsy-site using anti-CCL-2 neutralizing antibody resulted in a 3.25 (SD = 0.63) fold decrease in the number of migratory tumor cells compared to treatment with a control IgG antibody (Fig. 5c).